Pennant Group, Inc. (PNTG)
Services-Health Services · Healthcare · $1.2B
Intrinsic Value (Consensus)
$20.03
Current Price
$33.88
Margin of Safety
-40.9%
40.9% Above Intrinsic Value
Value: $20
Price: $34
Valuation Model Estimates
Current Price: $33.88
DCF (Discounted Cash Flow)
$48.93
Graham Number
$6.22
Earnings Power Value
$8.16
Relative Value (P/E)
$16.80
Dividend Discount Model
Not applicable
—
Consensus Value
$20.03
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
66
Profitability
25/25
Strength
12/25
Valuation
7/25
Growth
22/25
Financial Health Signals
Very high debt — Debt/Equity ratio is 237% (above 200% is risky)
Strong profitability — ROE of 42% (above 20% is excellent)
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $0.84
- EPS (Forward)
- $1.01
- Book Value
- $2.05
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 41.6%
- Debt/Equity
- 237%
- Revenue Growth
- 36.3%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance